Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BETR-001 shows antidepressant activity in preclinical models

April 7, 2022

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

April 7, 2022

Compass Pathfinder synthesizes new safrylamine derivatives

April 5, 2022

HCAR2 targeting modulates the progression of AD in mice

April 5, 2022

Molecular chaperone maintains proteostasis by clearing protein aggregates in cell

April 4, 2022

Discovery of alpha-syn aggregation inhibitors for the treatment of PD

April 4, 2022

LY-3372689, a novel OGA enzyme inhibitor for the treatment of Alzheimer's disease

April 4, 2022

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

March 31, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...